Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLUOCOL-1: Intraoperative Indocyanine Green Fluorescence Angiography in Colorectal Surgery
2024-515118-42-00Phase 4Authorised
- Sponsor
- CHRU Nancy
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of indocyanine green in colorectal cancer (CRC) (2 arms), sponsored by CHRU Nancy. Primary endpoint: Anastomotic leakage within 90 days. Planned start Sep 2024; status: authorised.
02
Drugs
indocyanine green
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2024-515118-42-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-515118-42-00.